Comment on decision by NICE not to recommend Kadcyla

Breast Cancer Campaign comments on the decision by the National Institute for Health and Care Excellence (NICE) not to recommend Kadcyla as a treatment for women with HER2+

Comment on new research into the gene PALB2 and breast cancer risk

Breast Cancer Campaign comments on research released today in the New England Journal of Medicine about the connection between mutations in the

Comment on link between oral contraceptives and developing breast cancer

News out today (1 August 2014) confirms our knowledge of the connection between oral contraceptives and developing breast cancer.

Comment on 100000 Genomes Project funding

Prime Minister David Cameron today announced £300m in funding for the 100,000 Genomics Project.

Comment on NICE draft recommendation for intrabeam radiotherapy

National Institute for Health and Care Excellence (NICE) has published draft guidance on the use of intrabeam radiotherapy as a treatment option for people with early breast cancer.

Comment on cancer waiting times statistics in England annual report 2013/14

The latest annual National Statistics on waiting times for suspected and diagnosed cancer patients accessing NHS services, produced by NHS England, were released on 25 July 2014 according to the arrangements approved by the UK Statistics Authority.

Breast Cancer Campaign co-funds Breast Surgical Specialty Lead in Royal College of Surgeons Clinical Trials Initiative

In partnership with the Association of Breast Surgery and Breakthrough Breast Cancer, Breast Cancer Campaign is part-funding a Breast Surgical Specialty Lead in the Royal College of Surgeons Clinical Trials Initiative.

Asda raise £40 million for Tickled Pink campaign

Asda raises £40 million for Tickled Pink campaign

Asda raise £40 million for Tickled Pink campaign

Following 17 years of essential fundraising, we are thrilled to announce that Asda’s Tickled Pink Campaign has raised a landmark £40 million for Breast Cancer Campaign and Breast Cancer Care.

Comment on statins could reduce the risk of breast cancer

Research has shown that statins could be used to reduce the risk of developing breast cancer after a link between the illness and high cholesterol was found in a study of more than 1 million patients over a 14 year time period in the UK.

Dr John F Marshall, Reader in Tumour Biology at Queen Mary University of London’s Barts Cancer Institute

Significant discovery could tackle spread of breast cancer

Dr John F Marshall, Reader in Tumour Biology at Queen Mary University of London’s Barts Cancer Institute

For the first time, researchers, funded by Breast Cancer Campaign, have shown that the molecule αvβ6 (alpha v beta 6) plays a fundamental role in helping breast cancer cells to grow and spread - and that the molecule is a viable new target for treating one of the most aggressive types of breast cancer.

Pages

Share this page

Latest Content

Most Read

Get In Touch

Address: Clifton Centre, 110 Clifton Street, London EC2A 4HT

Main Switchboard: 020 7749 4114

Media Enquiries (Office Hours):
020 7749 4115

Media Enquiries (Out of Hours):
07436 107914

Email: info@breastcancercampaign.org